The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002317:Cardiovascular Agents; D002415:Cats; D002417:Cattle; D003331:Coronary Vessels / Q000187:drug effects; D011464:Epoprostenol / Q000494:pharmacology*; D005260:Female; D006801:Humans; D016285:Iloprost; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count; D011453:Prostaglandins / Q000494:pharmacology*
D002317:Cardiovascular Agents; D011453:Prostaglandins; D011464:Epoprostenol; D016285:Iloprost